Reporter calls disclosure by nation’s drug-regulatory agency ‘shocking and unbelievable’ Nov. 2, 2022 Dear Friends: Anti-finasteride sentiment continues to run rife on Teutonic TV. Dürfen Die Das? (Can They Do That?), a newsmagazine show on the German public-broadcasting network NDR, last week debuted a 17-minute film titled Finasteride: Why Is This Hair-loss Drug Still on […]
Study marks first-ever demonstration of a successful PFS therapy in an animal model Oct. 29, 2022 Dear Friends: The neurosteroid allopregnanolone (ALLO) has proved effective in counteracting some of the finasteride-induced alterations in gut microbiota, according to new research at the University of Milano (UniMi). Titled Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of […]
Israeli pharmacovigilance expert, meanwhile, calls for ‘revolution’ in ADR reporting after local family of PFS suicide case files suit against Merck Sept. 26, 2022 Dear Friends: If you’ve ever Googled “post-finasteride syndrome,” chances are you’ve earned a place in the annals of medicine. Researchers at the University of Southern California’s Keck School of Medicine (KSM) […]
But Patient Product Information not revised to include the potentially lethal adverse events Aug. 29, 2022 Dear Friends: Organon & Co., the Merck & Co. spinoff that now owns Propecia (finasteride 1 mg), has added a new adverse drug reaction (ADR) to the hair-loss remedy’s label: suicidality. Earlier this month, Organon updated the Adverse Reactions […]
‘How-to’ video encourages reporting of finasteride ADRs to Ministry of Health July 13, 2022 Dear Friends: France’s National Agency for the Safety of Medicines and Health Products (ANSM) last week published a dossier of educational materials on the growing number of adverse drug reactions (ADRs) to finasteride 1 mg, as experienced by men currently suffering […]
June 27, 2022 Dear Friends: The PFS Foundation has launched an interactive map plotting all the nations known to have issued warnings of finasteride’s potential to cause persistent adverse reactions, aka post-finasteride syndrome (PFS). Fifty-three nations, from Argentina to the United States, currently comprise our PFS Global Warning Map. Each links to a table entry […]
Separately, safety signal of causal link between finasteride and diabetes mellitus issued by Saudi FDA in 2021 March 2, 2022 Dear Friends: In a confidential 2018 letter to health care professionals, Merck & Co.’s Saudi Arabian subsidiary warned that finasteride patients should be carefully monitored for psychiatric symptoms including anxiety, depression and suicidal ideation. Furthermore, […]
Jan. 22, 2022 Dear Friends: A new documentary examining three young men’s reactions to rapidly thinning locks—shaving, transplanting and finasteride—features an interview with eminent PFS researcher Roberto Cosimo Melcangi, PhD. Titled Plötzlich kahl (Suddenly Bald) the 30-minute film by Gustav Hofer (English-subtitled version here) debuted last month on SRF, the largest German-language broadcaster in Switzerland. […]
Jan. 10, 2022 Dear Friends: After enduring decades of symptoms that ran the gamut from tooth loss to testicular cancer, Ryan Clark prompted his nation’s drug agency to take a telemed to task for failing to adequately disclose finasteride’s dangers. And though he’d hoped for more significant action, the 54-year-old PFS patient from the northeast […]
Editorial in leading journal, meanwhile, criticizes FDA for not making Merck conduct new safety studies when persistent ED signal emerged Nov. 20, 2021 Dear Friends: A decade after the first peer-reviewed article on persistent adverse sexual effects in finasteride patients appeared in medical literature, the first-ever diagnostic criteria for PFS has followed suit. We have […]